Belvedere Trading LLC Seelos Therapeutics, Inc. Transaction History
Belvedere Trading LLC
- $74.4 Billion
- Q3 2024
A detailed history of Belvedere Trading LLC transactions in Seelos Therapeutics, Inc. stock. As of the latest transaction made, Belvedere Trading LLC holds 36,500 shares of SEEL stock, worth $9,125. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,500Holding current value
$9,125% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding SEEL
# of Institutions
1Shares Held
40.5KCall Options Held
0Put Options Held
0About SEELOS THERAPEUTICS, INC.
- Ticker SEEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 106,691,000
- Market Cap $26.7M
- Description
- Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...